Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-01-08 @ 2:13 AM
Study NCT ID:
NCT03988205
Status:
TERMINATED
Last Update Posted:
2022-07-19
First Post:
2019-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
Sponsor:
Medical College of Wisconsin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-12
First Submit QC Date:
None
Study First Post Date:
2019-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-04-17
Results First Submit QC Date:
None
Results First Post Date:
2022-07-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-17
Last Update Post Date:
2022-07-19
Last Update Post Date Type:
ACTUAL